Nadia Asif

29 Added | 1 Magazine | 2 Likes | @NadiaAsif | Keep up with Nadia Asif on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Nadia Asif”

Product Pipeline | Pfizer: One of the world's premier biopharmaceutical companies

Our Medicines in Development<p>Our priority is researching and developing products and treatments that will benefit patients around the world. And from …

New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas

<b>New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas</b><br>Prioritized Pipeline Marks Important Milestone …

Pfizer details plans to expand vaccine portfolio beyond Prevnar

Pfizer ($PFE) is an unusual player in the vaccine space. It is the fourth biggest vaccine company by revenue, yet almost wholly reliant on one …

Pfizer Pipeline Highlights

One of the world's premier biopharmaceutical companies

Pfizer Inc. (NYSE:PFE) and InnoPharma, Inc., a privately held pharmaceutical development company, today announced that they have entered into an …

MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for Parkinson's Disease

VICTORIA, BRITISH COLUMBIA, Sep 16, 2014 (Marketwired via COMTEX) -- MedGenesis Therapeutix Inc. ("MedGenesis"), a privately held biotechnology …

Biotechnology
Cancer

Pfizer bets on Duchenne MD treatment

Pfizer is moving forward in the race to find treatments for Duchenne muscular dystrophy (DMD), announcing enrollment of the first patient in a Phase …

Pfizer: One of the world's premier biopharmaceutical companies

Our Products<p>Counterfeit Medicines - Is The Threat Real Or Fake<p>The issue of counterfeit medicines is far more of a problem than most people …

Pfizer -- Largest Pharmaceutical Company In The World

How Pfizer Is Going To Rob You

Pfizer says Hospira purchase will close in early September

Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September.<p>The New York company said Monday regulators in the U.S. and Brazil cleared the deal. European …

Pfizer
Biotechnology

Is the Pfizer-Allergan Deal ‘Unpatriotic’?

One of the biggest mergers this year has turned into a story of corporate tax avoidance.<p>The headlines covering Pfizer and Allergan’s $160 billion merger deal evolved quickly on Monday: In the morning, they relayed an image of a blockbuster merger that will produce the world’s biggest pharmaceutical …

Income Tax
Pfizer

Pfizer plans to close site in UK, 120 jobs could go

Surprise move comes just a year after Pfizer chief executive Ian Read praised UK science<p>US pharmaceuticals giant Pfizer is planning to close a facility in Britain, with the loss of 120 jobs.<p>The company said on Thursday that the move is in response to a decision to cut investment in research and …

Biotechnology

Pfizer raised the price of over 100 drugs this year

Pfizer confirmed a 9.4% increase for heavily advertised pain drug Lyrica, which generated $2.3 billion in 2014 U.S. sales; a 12.9% increase for erectile dysfunction drug Viagra, which had 2014 U.S. sales of $1.1 billion; and a 5% increase for Ibrance, a novel breast cancer drug launched last year …

Pfizer

Report: Pfizer and Allergan are terminating their proposed megamerger

The companies are expected to announce the dissolution of the merger as early as Wednesday morning, The Wall Street Journal reported.<p>The $160 billion mega-deal was pitched as a way to help Pfizer cut its tax bill by moving to Ireland, where Allergan is based. The tax rate for corporations in …

Bernie Sanders

New tax-inversion rules kill proposed Allergan-Pfizer merger

The $150-billion proposed merger of Pfizer Inc. and Ireland-based Allergan has been scrapped, becoming the first casualty of an Obama administration crackdown on companies that avoid U.S. taxes by moving their headquarters overseas.<p>In issuing two new broad rules late Monday to deter so-called …

6 banks just lost more than $200 million on the Pfizer-Allergan collapse

The US Treasury Department on Monday tightened the rules around tax inversions, the type of transaction Pfizer was trying to pull off with Allergan.<p>US President Barack Obama spoke out against tax inversions a day later, saying these deals hurt ordinary Americans.<p>Through inversions, US companies …

Goldman Sachs

Pfizer isn't the only one affected by new tax rules — past inversion deals could be hit too

A corporate inversion typically involves a U.S. company "merging" with a smaller foreign firm in a country with a low corporate tax rate, and nominally moving its headquarters there. That way, profits that would be subject to the 35 percent U.S. corporate rate are instead taxable in the other …

Pfizer

15 Reasons to Buy Pfizer and Never Sell

Image source: Pfizer.<p>When it comes to investing in the stock market, there are very few certainties. However, one so-called trick of the trade that has proved worthy time and again is that holding high-quality stocks over the long term usually delivers consistent gains and real wealth creation over …

New Drugs Helped Pfizer Blow Past Earnings Expectations

Pfizer (pfe) reported first-quarter results that blew past analyst estimates, boosted by sales of its new cancer and arthritis treatments and the …

Biotechnology

Pfizer quarterly revenue soars 19.7 percent

The company's revenue rose to $13.01 billion in the first quarter, from $10.86 billion a year earlier.<p>Net income rose to $3.02 billion, or 49 cents per share, from $2.38 billion, or 38 cents per share.<p>Pfizer and Allergan Inc walked away from their $160 billion merger in April, citing new U.S. …

Pfizer

Pfizer CEO still interested in deals after losing Allergan | Reuters

NEW YORK (Reuters) - After a planned purchase of Allergan Plc (AGN.N) was scuttled by the U.S. government, Pfizer (PFE.N) Chief Executive Ian Read on Tuesday said he would consider another merger of any size, at any time, as long as the deal makes sense.<p>Ian Read, chief executive officer of Pfizer, …

Biotechnology